Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlethora Solutions Holdings Plc Regulatory News (PLE)

  • There is currently no data for PLE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Plethora Solutions Holdings Plc - Amendment

24 Nov 2015 16:38

This document replaces the 8.3 form issued on 18th November 2015.

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: HARGREAVE HALE LIMITED (for Discretionary Clients)
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

PLETHORA SOLUTIONS HOLDINGS PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A
(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

4 NOVEMBER 2015
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

NO

If YES, specify which:

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: ORDINARY 1p

Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 7,570,000 0.9195
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

7,570,000 0.9195

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Class of relevant security: FUNDRAISING WARRANTS 15p 2019

Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 755,556 0.7470
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

755,556 0.7470

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit
ORDINARY SALE 75,000 6.63P
ORDINARY SALE 1,927,777 6.575P
ORDINARY PURCHASE 150,000 5P

(b) Cash-settled derivative transactions

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit
NONE

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit
NONE

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)
NONE

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 24 NOVEMBER 2015
Contact name: DAVID CLUEIT

HARGREAVE HALE LTD

Telephone number: 01253 754739

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151124005881/en/

Copyright Business Wire 2015

Date   Source Headline
18th Nov 20154:56 pmBUSForm 8.3 - Plethora Solutions Holdings Plc
18th Nov 20158:08 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
17th Nov 20159:00 amRNSForm 8 (OPD) Plethora Solutions Holdings PLC
17th Nov 20159:00 amRNSForm 8 (OPD) (Regent Pacific Group Limited)
17th Nov 20159:00 amRNSForm 8 (OPD) (Plethora Solutions Holdings plc)
17th Nov 20158:09 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
16th Nov 20158:47 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
13th Nov 20158:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
12th Nov 20155:26 pmRNSUpdate in relation to Letters of Intent
12th Nov 20159:03 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
11th Nov 20153:14 pmRNSForm 8.3 - AMENDMENT Plethora Solutions Holdings
11th Nov 201510:54 amRNSForm 8.3 - Plethora Solutions Holdings PLC
11th Nov 20157:41 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
10th Nov 20158:32 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
10th Nov 20158:15 amRNSLetter of Intent Signed
9th Nov 20155:10 pmRNSHolding(s) in Company
9th Nov 20152:36 pmRNSForm 8.3 - Plethora Solutions Holdings Plc
9th Nov 201511:50 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
6th Nov 20153:20 pmRNSRULE 2.10 UPDATE
6th Nov 20159:14 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
5th Nov 20153:53 pmRNSForm 8.3 - Plethora Solutions Holdings Plc
5th Nov 20151:14 pmRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
5th Nov 20158:27 amRNSForm 8.3 - Regent Pacific Group Ltd
4th Nov 20156:28 pmRNSRULE 2.10 UPDATE
4th Nov 20154:35 pmRNSForm 8 (DD) - Plethora Solutions Holdings plc
4th Nov 201510:03 amRNSPossible Offer for Plethora Solutions Holdings plc
28th Oct 20152:21 pmRNSDirector's Shareholding
28th Aug 20154:21 pmRNSHalf Yearly Report
11th Jun 201512:00 pmRNSResult of AGM
5th Jun 201512:16 pmRNSAgreement with Regent Pacific
12th May 20157:01 amRNSBoard Appointment
27th Apr 20154:30 pmRNSHolding(s) in Company
15th Apr 20155:05 pmRNSHolding(s) in Company
13th Apr 20158:16 amRNSHolding(s) in Company
1st Apr 20157:00 amRNSDirector Dealing and Issue of Equity
30th Mar 20151:30 pmRNSFinal Results
13th Feb 20152:33 pmRNSDirector/PDMR Dealing
9th Jan 20155:00 pmRNSTo attend J.P. Morgan's 33rd Healthcare Conference
22nd Dec 20147:00 amRNSDirector/PDMR dealing
11th Dec 20147:00 amRNSAppointment of NOMAD and Broker
11th Nov 20147:00 amRNSCompany Update
10th Nov 20147:00 amRNSRecordati Upfront Payment Received
31st Oct 20147:00 amRNSChange of Adviser
7th Oct 20147:00 amRNSPSD502 to be marketed as Fortacin in the EU
3rd Oct 201411:11 amRNSHolding(s) in Company
30th Sep 20145:38 pmRNSTotal Voting Rights
29th Sep 20142:26 pmRNSIssue of Equity
29th Sep 20147:00 amRNSUpdate regarding the European License Agreement
23rd Sep 20145:28 pmRNSHolding(s) in Company
19th Sep 20142:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.